Regression of left ventricular hypertrophy in hypertension. Effects of prazosin therapy.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  American Journal of Medicine

• Publication date

  1989-01-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0002-9343(89)90134-4PMID 2521543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Left ventricular hypertrophy in hypertension and the effects of antihypertensive drug therapy.

  1988cited by this paper
• Iodine-123 phenylpentadecanoic acid and single photon emission computed tomography in identifying left ventricular regional metabolic abnormalities in patients with coronary heart disease: comparison with thallium-201 myocardial tomography.

  1988cited by this paper
• Vasodilators and regression of left ventricular hypertrophy. Hydralazine versus prazosin in hypertensive humans.

  1987cited by this paper
• Reversal of cardiac hypertrophy by medical treatment.

  1985cited by this paper
• Determination of left ventricular mass using single-photon emission computed tomography.

  1985cited by this paper
• Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy.

  1983cited by this paper
• Regression of myocardial hypertrophy and influence of adrenergic system.

  1983cited by this paper
• Clinical determinants and consequences of left ventricular hypertrophy.

  1983cited by this paper
• Hemodynamics and other determinants in development of left ventricular hypertrophy.

  1983cited by this paper
• Prevalence and natural history of electrocardiographic left ventricular hypertrophy.

  1983cited by this paper
• Hemodynamics and other determinants in development of left ventricular hypertrophy.

  1983cited by this paper
• Time course of regression of left ventricular hypertrophy in treated hypertensive patients.

  1982cited by this paper
• Assessment of Regional Myocardial Uptake and Metabolism of ω-(p-123I-Phenyl) Pentadecanoic Acid with Serial Single-Photon Emission Tomography

  1982cited by this paper
• A new radioiodination method utilizing organothallium intermediate: Radioiodination of phenyl pentadecanoic acid (PPA) for potential applications in myocardial imaging

  1982cited by this paper
• Effect of beta-receptor-blocking agents on cardiovascular structural changes in spontaneous and noradrenaline-induced hypertension in rats.

  1980cited by this paper
• Emission computed tomography

  1979cited by this paper
• Regression of left ventricular hypertrophy during treatment with antihypertensive agents.

  1979cited by this paper
• Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements

  1978cited by this paper
• Norepinephrine--the myocardial hypertrophy hormone?

  1976cited by this paper
• Cardiac Hypertrophy in Spontaneously Hypertensive Rats

  1974cited by this paper
• Effects of Angiotensin II on DNA, RNA and Protein Synthesis

  1972cited by this paper
• Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study.

  1969cited by this paper

• Concentric vs. Eccentric Left Ventricular Hypertrophy: Does It Matter? It Is All "Blood Pressure Centered".

  2021cites this paper
• Reversing effects of DDPH on cardiac hypertrophy and increased collagen content induced by partial narrowing of abdominal aorta

  2008cites this paper
• Determinants of the short‐term gastric damage caused by NSAIDs in man

  2007cites this paper
• The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition

  2001cites this paper
• The effect of enalapril and verapamil on the left ventricular hypertrophy and the left ventricular cardiomyocyte numerical density in rats submitted to nitric oxide inhibition.

  2001cites this paper
• Coronary vasodilator reserve in left ventricular hypertrophy.

  2001cites this paper
• NSAIDs: a Faustian bargain.

  2000cites this paper
• Regression of left ventricular hypertrophy: do antihypertensive classes differ?

  2000cites this paper
• Regression of left ventricular hypertrophy; what are appropriate therapeutic objectives?

  1999cites this paper
• Effects of 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino) propane hydrochloride on heart function, lactate dehydrogenase and its isoenzymes in rats with cardiac hypertrophy.

  1998cites this paper
• Reversing effects of DDPH on cardiac hypertrophy and increased collagen content induced by partial narrowing of abdominal aorta.

  1997cites this paper
• Reserpine: A tragic victim of myths, marketing, and fashionable prescribing

  1996cites this paper
• Effect of indapamide on left ventricular hypertrophy in hypertension: a meta-analysis.

  1996cites this paper
• Left Ventricular Hypertrophy

  1995cites this paper
• Left ventricular hypertrophy. Prevalence in older patients and management.

  1995cites this paper
• Effects of antihypertensive drugs on cardiac hypertrophy.

  1994cites this paper
• Relationship between the regression of left ventricular hypertrophy and the changes in circadian blood pressure after long-term treatment with enalapril in hypertensive patients.

  1994cites this paper
• Hypertension and Left Ventricular Hypertrophy: Is Drug Therapy Beneficial?

  1994cites this paper
• Renoprotective effect of nisoldipine in rats with severe hypertension

  1994cites this paper
• Pathophysiological principles of the relation between myocardial hypertrophy of the left ventricle and its regression.

  1994cites this paper
• Long-term alpha 1 blockade does not reverse cardiac hypertrophy in spontaneously hypertensive rats.

  1993cites this paper
• Management of the patient with left ventricular hypertrophy.

  1993cites this paper
• Adrenergic mechanisms in left ventricular hypertrophy: significance and clinical implications.

  1993cites this paper
• Antihypertensive Therapy in the Geriatric Patient: II. A Review of the Alpha1‐Adrenergic Blocking Agents

  1993cites this paper
• Clinical applications of alpha 1-receptor blockade: terazosin in the management of hypertension. Introduction.

  1993cites this paper
• Selective alpha-1 inhibitors: first- or second-line antihypertensive agents?

  1993cites this paper
• Orthostatic Hypotension during Antihypertensive Treatment with Bunazosin and Prazosin

  1993cites this paper
• Clinical Applications of Alpha1‐Receptor Blockade: Terazosin in the Management of Hypertension

  1993cites this paper
• Prevention of NSAID-induced ulcers by the coadministration of misoprostol: implications in clinical practice.

  1992cites this paper
• Left Ventricular Hypertrophy

  1992cites this paper
• Alpha-blocker therapy of hypertension. An unfulfilled promise.

  1991cites this paper
• α-Blocker Therapy of Hypertension: An Unfulfilled Promise

  1991cites this paper
• Recent developments in 99mTc and 123I-radiopharmaceuticals for SPECT imaging.

  1991cites this paper
• Non‐steroidal anti‐inflammatory drug‐induced gastroduodenal injury: therapeutic recommendations

  1991cites this paper
• Plötzlicher Herztod und hypertensive Herzkrankheit

  1991cites this paper
• Interstudy reproducibility of dimensional and functional measurements between cine magnetic resonance studies in the morphologically abnormal left ventricle.

  1990cites this paper
• Radioiodinated tracers for myocardial imaging.

  1990cites this paper
• ALPHA-BLOCKADE FOR HYPERTENSION

  1989cites this paper
• Alpha-blockade for hypertension.

  1989cites this paper
• Regression of left ventricular hypertrophy in hypertension with alpha-adrenergic blockade: physiological basis and therapeutic implications.

  1989cites this paper
• Treatment strategies: an evaluation of antihypertensive therapy.

  1989cites this paper
• Left ventricular hypertrophy in hypertension and the effects of antihypertensive drug therapy.

  1988cites this paper